Table 2.
Laboratory findings of studied FMF patients at the time of study.
| Variable | Range | Mean ± SD |
|---|---|---|
| Hemoglobin (gm/dL) | 10.1–13.9 (71) | 12.3 ± 0.9 |
| Total leucocytic count (×1000/µL) | 3.8–23.4 (71) | 7.7 ± 3.2 |
| Platelet count (×1000/µL) | 134–523 (71) | 317 ± 78.2 |
| ESR (mm/hr) | ||
| <15 | 3–14 (21/71, 29.6%) | 9.6 ± 3.4 |
| ≥15 | 15–90 (50/71, 70.4%) | 38.1 ± 16.7 |
| CRP Titer | ||
| Positive | 2.4–48 (22/71, 31%) | 15.4 ± 12.8 |
| Negative | 0 (49/71, 69.0%) | |
| Serum amyloid A (SAA) (mg/L) | ||
| <30 mg/L | 13.7–29.5 (15/71, 21.1%) | 24.8 ± 4.8 |
| ≥30 mg/L | 32.6–129.2 (56/71, 78.9%) | 81.62 ± 31.6 |
Number in parentheses is number of patients.
Only 5 patients (7%) had TLC 13.7–23.4 × 103 per microliter of blood.
The median SAA level was 76.1 mg/L (for the range 13.7–129.2 mg/L).